Professor Debby Mangelings from the Vrije Universiteit in Belgium, estimates that 60% of newly commercialized drugs possess chiral properties. In this interview with Bethany Degg of The Column, Mangelings discusses the importance of chiral chromatography in pharmaceutical analysis, the challenges of current methods, and where the field is heading next.
Professor Debby Mangelings from the Vrije Universiteit in Belgium, estimates that 60% of newly commercialised drugs possess chiral properties. In this interview with Bethany Degg of The Column, Mangelings discusses the importance of chiral chromatography in pharmaceutical analysis, the challenges of current methods, and where the field is heading next.